Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Cross-Border Impact Ventures is a Toronto-based impact venture capital firm established to enhance health technology investments with a specific focus on addressing gender health inequalities. Founded with the mission to improve health technologies for women, children, and adolescents worldwide, the firm operates primarily in North America, Europe, and Latin America. With a portfolio of eight innovative companies, Cross-Border Impact Ventures aims to create a significant social impact while achieving financial returns. The firm is committed to investing in sectors that include healthcare, biotech, digital health, and femtech, reflecting its dedication to improving health outcomes for underserved populations.
The leadership team at Cross-Border Impact Ventures brings a wealth of experience in both venture capital and healthcare, ensuring that their investments are not only financially sound but also socially responsible. The firm’s approach is characterized by a thorough understanding of the health technology landscape and a commitment to fostering innovations that can lead to transformative changes in health systems. By focusing on low- and middle-income countries, as well as developed markets, Cross-Border Impact Ventures positions itself as a key player in the global health technology ecosystem.
Cross-Border Impact Ventures specializes in investing in health technology companies that develop medical devices, diagnostics, therapeutics, and digital health innovations. The firm is particularly focused on addressing gender health inequalities, seeking opportunities that yield both positive social impact and financial returns. Their investment strategy emphasizes sectors such as sexual and reproductive health, maternal and child health, and chronic disease management. By targeting companies that align with these themes, Cross-Border Impact Ventures aims to support innovations that can significantly improve health outcomes for women and children.
The firm typically invests at the Seed, Series A, and Series B stages, allowing them to engage with startups at various points in their development. Cross-Border Impact Ventures looks for companies that not only demonstrate strong growth potential but also have a clear mission to address pressing health disparities. Their geographic focus spans North America, Europe, and Latin America, reflecting a commitment to enhancing health technologies in diverse markets. By prioritizing investments that tackle gender health issues, the firm seeks to create a lasting impact on global health systems.
Cross-Border Impact Ventures boasts a diverse portfolio of eight companies that exemplify its commitment to health technology and gender health initiatives. Notable investments include **Pendulum**, a health infrastructure software company leveraging AI and machine learning to optimize supply chain management in healthcare. **Raydiant Oximetry** has developed non-invasive devices for monitoring fetal oxygen levels, while **Sonio** enhances fetal ultrasound practices through AI-enabled software. **OncoLens** provides oncology care management solutions via its digital health platform, and **mOm Incubators** produces a low-cost, portable incubator for newborns.
Additionally, **Daye** focuses on gynecological health as a leading Femtech company, and **Axena Health** is commercializing a device aimed at treating urinary incontinence. **Oxford Cancer Analytics** is also part of the portfolio, developing a biomarker discovery platform for cancer detection. This varied portfolio not only highlights the firm’s investment strategy but also its dedication to addressing critical health challenges faced by women and children globally.
Cross-Border Impact Ventures invests in companies at the Seed, Series A, and Series B stages. This allows them to support startups at various points in their growth journey, from early development to scaling operations.
The firm focuses on health technology investments, particularly in sectors such as healthcare, biotech, digital health, and femtech. They are dedicated to addressing gender health inequalities through their investment strategy.
While specific check sizes are not detailed in the source material, the firm typically invests in early to mid-stage companies, which suggests they are likely to provide funding that aligns with the needs of startups at the Seed, Series A, and Series B stages.
Cross-Border Impact Ventures primarily invests in North America, Europe, and Latin America. This geographic focus allows them to engage with diverse markets and address health disparities in various regions.
The source material does not provide specific details about the application process. However, interested founders are encouraged to reach out directly to the firm for guidance on pitching their ideas.
While specific support mechanisms are not outlined, Cross-Border Impact Ventures is known for its commitment to fostering innovations that address health disparities, suggesting they may offer strategic guidance and resources to their portfolio companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.